Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 882.00, up by 40.20 points or 4.78 % from its previous closing of Rs. 841.80 on the BSE.

The scrip opened at Rs. 844.00 and has touched a high and low of Rs. 884.90 and Rs. 844.00 respectively. So far 393790 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 748.15 on 26-Sep-2014.

Last one week high and low of the scrip stood at Rs. 884.90 and Rs. 831.80 respectively. The current market cap of the company is Rs. 208294.27 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 31.51% and 13.78% respectively.

Sun Pharmaceutical Industries has reported a net loss of Rs 387.10 crore for the quarter ended June 30, 2015 as compared to a net profit of Rs 802.68 crore for the same quarter in the previous year. The company’s total income has decreased by 30.26% to Rs 2021.85 crore for the quarter under review from Rs 2898.99 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 60.24% fall in its net profit after taxes and Minority Interest at Rs 478.96 crore for the quarter ended June 30, 2015 as compared to Rs 1204.59 crore for the same quarter in the previous year. However, total income of the company has increased by 5.21% at Rs 6862.96 crore for quarter under review as compared to Rs 6523.13 crore for the quarter ended June 30, 2014.